This is an old revision of the document!
Zhengli Shi
History
Education
Shi earned her masters degree from the Wuhan Institute of Virology in 1990. Later, she earned her PhD in France at the Montpellier 2 University while becoming fluent in French.
Career
Director of Wuhan Institute of Virology
Coronavirus Research
2005
In the wake of the 2002-2003 SARS-CoV outbreak, Shi and collegues found that bats are a natural reservoir of SARS-like CoVs.1)
2013
In 2013, researchers at the Wuhan Institute of Virology published a paper saying that Dr. Zhengli Shi and EcoHealth Alliance's Dr. Peter Daszak found CoVs that were 95% identical to human SARS-CoV in Chinese horseshoe bats. Further, these CoVs “were able to use human angiotensin-converting enzyme 2 (ACE2) receptor for docking and entry.”2)
2020
In March 2020, Shi and co-authors published a paper asserting that Remdesivir and chloroquine worked as therapeutics against SARS-CoV-2.3)
1)
october 31, 2005 | Li Wendong et al including Shi Zhengli and Peter Daszak | Science (journal) | Bats Are Natural Reservoirs of SARS-Like Coronaviruses | https://doi.org/10.1126/science.1118391
2)
December, 2013 | Manli Wang and Zhihong Hu | Virol Sin. (journal) | Bats as animal reservoirs for the SARS coronavirus: Hypothesis proved after 10 years of virus hunting | doi: 10.1007/s12250-013-3402-x
3)
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/10.1038/s41422-020-0282-0